T1	Participants 45 102	cystoid macular oedema in patients with Behcet's disease.
T2	Participants 180 211	patients with Behcet's disease.
T3	Participants 233 326	A total of 67 eyes of 35 Behcet's patients with chronic, but well-controlled uveitis, and CMO
T4	Participants 756 830	29 patients (55 eyes) completed the trial and were available for analysis.
T5	Participants 831 867	Of the 29, 16 men and 13 were women.
T6	Participants 868 916	The age range was 13-50 years (mean 33.6 years).
T7	Participants 1685 1712	Behcet's patients with CMO.
